Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

The World Is Changing Faster than Sunrun Can Handle

Sunrun is expecting a "Biden bump" from his green energy proposals, but RUN stock is unprepared for solar becoming a consumer product.

7 Value Stocks To Buy Today For Security And Consistency

Value stocks offer your portfolio protection for past gains, and dividends for future income. Here are 7 to consider.

SunPower Offers the Sizzle of Solar Power Without the Gristly Steak

Analysts are upgrading SPWR stock. But SunPower has gone from a domestic maker of solar panels to a financing and power sales company.

How Plug Power Is Evolving Into a Hydrogen Supplier

Plug Power has bought a company that captures hydrogen from a chlor-alkali plant, and a company that can help create hydrogen fuel stations

Robinhood and Momentum Investing: The New Day Trading

Robinhood can offer no-fee trading because it sells your order flow to professionals who know how to fleece you for your naivete.

Cronos Group Is a Shaky Bet in a Post-Pandemic World

Altria paid $1.8 billion for 45% of pot producer Cronos in 2019, but now all of Cronos Group stock is worth no more than that.

Pfizer Is a Value Play in the Covid-19 Frenzy

Most drug stocks are very expensive, but PFE stock is a Covid-19 vaccine play that is still selling at a reasonable price.

Papa John’s Is Set to Deliver Big, Delicious Profits

Papa John's is taking full advantage of a flurry of pandemic-related business with rapid expansion. Expect big profits for PZZA stock.

AMD’s Soaring Valuation Is Hard to Justify

Shares of AMD stock have risen 90% in 2020, as it puts Intel in its rear-view mirror. But can the company really compete with Nvidia?

If Biden Can Save General Motors for a Second Time, How About GM Stock?

Vice President Biden is promising a host of programs that would boost GM's efforts to compete in electric cars. GM stock looks poised to respond.